Long-term data of BRS

Session comprising selected EuroPCR 2017 abstract submissions

Chairperson: P.W. Serruys
Panellists: R. Diletti, A. Lafont

Presentations available when logged in:

  • Multicentre, post-marketing evaluation of the Elixir DESolve novolimus-eluting coronary BRS system: 12-month results from the DESolve PMCF study
  • Bioresorbable everolimus-eluting vascular scaffold for the treatment of long coronary lesions: the Long-ABSORB registry
  • Long-term follow-up of BRS implantation for complex coronary lesions: a multicentre experience
  • Long-term follow-up of late-acquired incomplete stent apposition in CTO treated with BRS
  • Long-term clinical outcomes of BRS to treat all-comer coronary artery disease: single-centre experience
  • Bioresorbable everolimus-eluting vascular scaffolds for type B2/C coronary lesions: a three-year follow-up
  • Everolimus-eluting BRS: impact of lesions complexity on clinical outcome and predictors of adverse cardiac events at long-term follow-up